Elevated [qlco]    
SERUM [bdsu]    
Levels [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Hepatitis C [dsyn]    
Patients [podg]    
Recently [tmco]    
Fibrosis, Liver [dsyn]    
Unique [qlco]    
FIBROSIS [patf]    
Related [qlco]    
Evaluated [hlca]    
Ability [orga]    
M2BP [gngm]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Infected [fndg]    
HEPATITIS C VIRUS [virs]    
Patients [podg]    
admitted [hlca]    
chronic Hepatitis C virus infection [dsyn]    
Risk Factors [qnco]    
Evaluated [hlca]    
Ability [orga]    
M2BP [gngm]    
HEPATOCELLULAR CARCINOMA [neop]    
Evaluated [hlca]    
included [ftcn]    
Sex [orgf]    
Viral Load [fndg]    
Genotypes [orga]    
Fibrosis stage [clna]    
Alanine Aminotransferase level [lbtr]    
Platelet Count [lbpr]    
M2BP [gngm]    
Response [orga]    
therapy [ftcn]    
SERUM [bdsu]    
M2BP [gngm]    
Levels [qlco]    
Increased [qnco]    
Progression [patf]    
Fibrosis, Liver [dsyn]    
Stage [tmco]    
Stage [tmco]    
FIBROSIS [patf]    
F2 [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Increased [qnco]    
Elevation [topp]    
M2BP [gngm]    
Identified [qlco]    
YEARS [tmco]    
M2BP [gngm]    
M2BP [gngm]    
Response [orga]    
therapy [ftcn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Independent [idcn]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
TIME [tmco]    
Dependent [qlco]    
Receiver Operating Characteristic [qnco]    
Curve [spco]    
M2BP [gngm]    
Assay [lbpr]    
Predicted [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
Diagnostic Accuracy [qlco]    
M2BP [gngm]    
Applied [ftcn]    
Useful [qlco]    
Surrogate Marker [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Liver Biopsy [diap]    
